Vaccine Production in Africa: A Feasible Business Model for Capacity Building and Sustainable New Vaccine Introduction

by Geofrey Makenga, Stefano Bonoli, Emanuele Montomoli, Trent Carrier, Joachim Auerbach
Published 2019-03-01

A Phase 2a Randomized Study to Evaluate the Safety and Immunogenicity of the 1790GAHB Generalized Modules for Membrane Antigen Vaccine against Shigella sonnei Administered Intramus...

by Christina W. Obiero, Augustin G. W. Ndiaye, Antonella Silvia Sciré, Bonface M. Kaunyangi, Elisa Marchetti, Ann M. Gone, Lena Dorothee Schütte, Daniele Riccucci, Joachim Auerbach, Allan Saul, Laura B. Martin, Philip Bejon, Patricia Njuguna, Patricia Njuguna, Audino Podda
Published 2017-12-01

Booster Vaccination With GVGH Shigella sonnei 1790GAHB GMMA Vaccine Compared to Single Vaccination in Unvaccinated Healthy European Adults: Results From a Phase 1 Clinical Trial

by Odile Launay, Odile Launay, Odile Launay, Augustin G. W. Ndiaye, Valentino Conti, Pierre Loulergue, Pierre Loulergue, Pierre Loulergue, Antonella Silvia Sciré, Anais Maugard Landre, Anais Maugard Landre, Anais Maugard Landre, Pietro Ferruzzi, Naouel Nedjaai, Naouel Nedjaai, Naouel Nedjaai, Lena Dorothee Schütte, Joachim Auerbach, Elisa Marchetti, Allan Saul, Laura B. Martin, Audino Podda
Published 2019-03-01

Efficacy, safety, and immunogenicity of the Shigella sonnei 1790GAHB GMMA candidate vaccine: Results from a phase 2b randomized, placebo-controlled challenge study in adults

by Robert W. Frenck, Jr, Valentino Conti, Pietro Ferruzzi, Augustin G.W. Ndiaye, Susan Parker, Monica Malone McNeal, Michelle Dickey, Juan Paolo Granada, Giulia Luna Cilio, Iris De Ryck, Francesca Necchi, Akamol E. Suvarnapunya, Omar Rossi, Alessandra Acquaviva, Lakshmi Chandrasekaran, Kristen A. Clarkson, Joachim Auerbach, Elisa Marchetti, Robert W. Kaminski, Francesca Micoli, Rino Rappuoli, Allan Saul, Laura B. Martin, Audino Podda
Published 2021-09-01